Open original FDA record ↗Recall record
- FDA identifier
- Z-1838-2016
- Company in FDA record
- Baxter Healthcare Corp
- FDA classification date
- May 31, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for incomplete dissolution of the polyethylene glycol (PEG) component during the reconstitution of the product, which may affect the consistency of the hydrogel formation during use.
Source facts
- Action
- An Urgent Product Recall letter dated 5/13/16 was sent to customers to inform them that Baxter Healthcare Corporation is issuing a voluntary product recall for the product codes and lots listed below due to the potential for incomplete dissolution of the polyethylene glycol (PEG) component during the reconstitution of the product, which may affect the consistency of the hydrogel formation during use. The letter provides the customers with the list of affected products, hazards involved, and actions to be taken. Customers with questions regarding the recall communication, are instructed to contact Baxter Product Surveillance at (800) 437-5176, 8-5pm, Monday-Friday.
- Initiated
- 2016-05-12
- Root cause
- Nonconforming Material/Component
- Terminated
- 2017-03-23
- Distribution
- Distributed US (nationwide) including Puerto Rico and in the Bahamas, Canada, and Singapore.
- Recall number
- Z-1838-2016
- Recall status
- Terminated
- CDRH record ID
- 146449
- FDA classified
- 2016-05-31
- Recall event number
- 74139